Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 169.50K | 166.00K | 153.40K | 143.20K | 116.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83M | 1.85M | 215.70K | 187.70K | 151.50K |
| Operating Income | -1.83M | -1.85M | -215.70K | -187.70K | -151.50K |
| Income Before Tax | -1.83M | -1.85M | -216.50K | -188.50K | -152.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.83 | -1.85 | -0.22 | -0.19 | -0.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.83M | -1.85M | -216.50K | -188.50K | -152.30K |
| EBIT | -1.83M | -1.85M | -215.70K | -187.70K | -151.50K |
| EBITDA | -1.82M | -1.84M | -207.10K | -180.50K | -132.00K |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 594.80M | 587.03M | 581.20M | 541.84M | 495.29M |
| Average Diluted Shares Outstanding | 594.80M | 587.03M | 581.20M | 541.84M | 495.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |